SEC Form 4 · accession 0000899243-18-024446
T2 Biosystems, Inc. · TTOO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alec Barclay
Officer — SVP, Operations
Period of report
Sep 11, 2018
Accepted (ET)
Sep 13, 2018 · 5:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492674
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 11, 2018 | M | 10,000 | — | A | 37,155 | D | |
| Common Stock | Sep 12, 2018 | F | 3,522 | $6.49 | D | 33,633 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1,F2 | — | Sep 11, 2018 | M | 10,000 | D | — | — | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- F2The restricted stock units vest in two annual installments beginning on September 11, 2017.